產(chǎn)品描述: | XL147 analogue is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ. |
靶點(diǎn): |
Apoptosis;DNA-PK;PI3K;PI3K |
體內(nèi)研究: |
XL147濃度為20 μM時(shí)誘導(dǎo)細(xì)胞死亡。用XL147處理導(dǎo)致PI3K的劑量依賴性抑制。抑制細(xì)胞凋亡的同時(shí),XL147誘導(dǎo)細(xì)胞周期蛋白D1和pRB的減少和CDK抑制劑p27KIPI水平的增加,但是在總的或切割的多聚(ADP-核糖)聚合酶(PARP)上水平?jīng)]有可檢測(cè)到的變化。用XL147處理,導(dǎo)致pAKTS473/T308和pS6S240/244的劑量依賴性減少。XL147是選擇性的可逆PI3K抑制劑,作用于p110α?xí)rIC50為40 nM。XL147抑制PI3K亞型,是ATP競(jìng)爭(zhēng)性抑制劑。在一組HER2過(guò)表達(dá)人乳腺癌細(xì)胞系中,用XL147處理消除AKT和S6磷酸化,但也誘導(dǎo)HER??3和其他RTK的表達(dá)和磷酸化。在HER2 +細(xì)胞中,用siRNA抑制HER3或用HER2抑制劑曲妥珠單抗或拉帕替尼共處理可增強(qiáng)XL147誘導(dǎo)的細(xì)胞死亡和對(duì)pAKT和pS6的抑制作用 |
細(xì)胞實(shí)驗(yàn): |
Cells including BT474, HCC1937 et al. are seeded in 100-mm dishes in media containing 2.5% FBS with or without XL147. After 3 days, detached and adherent cells are pooled, xed, and labeled with propidium iodide by using the APO-BrdU kit. Labeled cells are analyzed using the Becton Dickinson FACSCalibur system. (Only for Reference) |
參考文獻(xiàn): |
1.2010 ASCO Annual Meeting 2.Chakrabarty A, et al. Proc Natl Acad Sci U S A, 2011, 1-6. |
溶解性: |
DMSO:22.45 mg/mL(50.1 mM) Ethanol:<1 mg/mL H2O:<1 mg/mL |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
2.23 ml |
11.148 ml |
22.296 ml |
5 mM |
0.446 ml |
2.23 ml |
4.459 ml |
10 mM |
0.223 ml |
1.115 ml |
2.23 ml |
50 mM |
0.045 ml |
0.223 ml |
0.446 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |